This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Combescure C, Machecourt J, Foote A, Castelli C, Danchin N, Vanzetto G, Daures JP.SES is cost effective in treatment of diabetic patients with multiple vessel disease, but leads to a relatively high stent thrombosis rate: the EVASTENT study ESC Congress 2009: Annual Congress of the European Society of Cardiology: abstr. P1492, 29 Aug 2009. Available from: URL: http://www.escardio.org
Addad F, Cheriaa S, Lahidheb D, Dridi Z, Barraket N, Betbout F, Hassine M, Filali T, Gamra H, Haouala H.Cost-effectiveness of drug-eluting stents compared to bare-metal stents in diabetic patients: a bicentric case-control matched study ESC Congress 2009: Annual Congress of the European Society of Cardiology: abstr. P4042, 29 Aug 2009. Available from: URL: http://www.escardio.org
Rights and permissions
About this article
Cite this article
Drug-eluting stents appear favourable for diabetic patients. Pharmacoecon. Outcomes News 587, 4 (2009). https://doi.org/10.2165/00151234-200905870-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905870-00008